Investor.seagen.com is a subdomain of Seagen.com, which was created on 1997-12-05,making it 26 years ago.
Description:Explore Seagen's investor relations page for key financial information, news updates, and resources for prospective investors. ...
Keywords:Seagen, investor relations, financial reports, stock information, corporate governance, shareholder services, sustainability, ESG report....
Discover investor.seagen.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
HomePage size: 236.424 KB |
Page Load Time: 0.178288 Seconds |
Website IP Address: 13.107.213.69 |
Masonite International Corp. - Investor Relations - Investor Relations investor.masonite.com |
Block, Inc. (SQ) Investor Relations - Investor Relations investors.block.xyz |
Gen Investor Relations - Investor Relations investor.gendigital.com |
MindChamps PreSchool Limited - Investor Relations: Investor Relations investor.mindchamps.org |
Home - Ayala Land Investor Relations : Ayala Land Investor Relations ir.ayalaland.com.ph |
Universal Technical Institute's Investor Relations - UTI Investor Relations uti.investorroom.com |
Ameriprise Financial Investor Relations | Investor Relations ir.ameriprise.com |
Meridian Bank Investor Relations - Meridian Bank Investor Relations investor.meridianbanker.com |
Armstrong World Industries Investor Relations | Armstrong Flooring Investor Relations ir.armstrong.com |
Walmart Investor Relations - Investor Relations stock.walmart.com |
Alphabet Investor Relations - Investor Relations - Alphabet investor.google.com |
Investor Relations | Jacobs - Investor Relations invest.jacobs.com |
Pfizer Inc. - Investor Relations https://investor.seagen.com/ |
Pfizer Inc. - Investor Relations https://investor.seagen.com/overview/default.aspx |
Pfizer Inc. - Investor Relations - Events & Presentations https://investor.seagen.com/events-and-presentations/default.aspx |
Truist Securities BioPharma Symposium https://investor.seagen.com/Investors/Events--Presentations/event-details/2023/Truist-Securities-BioPharma-Symposium-2023-CPzwA1pcoq/default.aspx |
6th Annual Evercore ISI HealthCONx Conference https://investor.seagen.com/Investors/Events--Presentations/event-details/2023/6th-Annual-Evercore-ISI-HealthCONx-Conference-2023-bT_IVAa7tQ/default.a |
Fourth Quarter 2023 https://investor.seagen.com/Investors/Events--Presentations/event-details/2024/Pfizer-Quarterly-Corporate-Performance--Fourth-Quarter-2023-2024-Nch_DR |
Pfizer Analyst and Investor Call to Review Full-Year 2024 ... https://investor.seagen.com/Investors/Events--Presentations/event-details/2023/Pfizer-Analyst-and-Investor-Call-to-Review-Full-Year-2024-Financial-Gui |
Seagen - Seattle Genetics Announces Potential Accelerated Approval ... https://investor.seagen.com/press-releases/news-details/2020/Seattle-Genetics-Announces-Potential-Accelerated-Approval-Pathway-in-the-US-for-PADCEV-en |
Seagen - Seattle Genetics Highlights Data from Expanding Oncology ... https://investor.seagen.com/press-releases/news-details/2020/Seattle-Genetics-Highlights-Data-from-Expanding-Oncology-Portfolio-During-Virtual-Scienti |
Seattle Genetics Reports Third Quarter 2019 Financial Results https://investor.seagen.com/press-releases/news-details/2019/Seattle-Genetics-Reports-Third-Quarter-2019-Financial-Results/ |
Seagen - Seattle Genetics Announces Proposed Public Offering of Common ... https://investor.seagen.com/press-releases/news-details/2019/Seattle-Genetics-Announces-Proposed-Public-Offering-of-Common-Stock/default.aspx |
Date: Sat, 11 May 2024 11:36:37 GMT |
Content-Type: text/html; charset=utf-8 |
Transfer-Encoding: chunked |
Connection: keep-alive |
CF-Ray: 8821df4f6ece0fec-LAX |
CF-Cache-Status: REVALIDATED |
Cache-Control: public, max-age=10, stale-if-error=86400, stale-while-revalidate=86400 |
Strict-Transport-Security: max-age=31536000; includeSubDomains |
Vary: Accept-Encoding |
X-Content-Type-Options: nosniff |
X-Frame-Options: SAMEORIGIN |
X-XSS-Protection: 1; mode=block |
Server: cloudflare |
content="text/html; charset=utf-8" http-equiv="Content-type"/ |
content="RevealTrans(Duration=0,Transition=0)" http-equiv="Page-Enter"/ |
content="IE=edge,chrome=1" http-equiv="X-UA-Compatible"/ |
content="width=device-width, initial-scale=1.0" name="viewport"/ |
content="default-src 'self' https: http: 'unsafe-inline' 'unsafe-eval' *.q4inc.com; script-src 'self' *.cloudfront.net *.adobetm.com *.pusherapp.com *.newrelic.com *.nr-data.net *.bugherd.com *.q4cdn.com *.q4web.com *.amazonaws.com *.highcharts.com *.googletagmanager.com *.googleadservices.com *.google-analytics.com *.google.com *.gstatic.com *.q4app.com *.pendo.io *.adobedtm.com *.digitalpfizer.com *.youtube.com 'unsafe-inline' 'unsafe-eval' *.q4inc.com" http-equiv="Content-Security-Policy"/ |
content="aj8BuwMZqALcTkImAzzlPq7gwURoq9nhp_ygeaawd_k" name="google-site-verification"/ |
content="HlPPIdKZStmoXkooZASg1-xlI1LES7ZA9YtYiGVUqsM" name="google-site-verification"/ |
Ip Country: United States |
Latitude: 37.751 |
Longitude: -97.822 |
Overview Investor Relations Overview Why Invest Our Story Prospective Investors Sustainability Bond ESG Report Fact Sheet Investor Email Alerts EventsPresentations Financials Quarterly Results Annual Reports SEC Filings News Stock Info Stock Quote Stock Chart Historical Stock Quote Investment Calculator DividendSplit History Stock FAQs Corporate Governance Corporate Governance Overview Board of Directors Board CommitteesCharters Corporate Governance Documents Board Policies Corporate Governance FAQs Contact Our Directors More Resources Shareholder Services Shareholder Services Overview Pfizer Investor Insights Stock FAQs Cost Basis Calculator Science Clinical Trials Guide to Clinical Trials Your participation makes a difference Clinical Trials in Children Designed to improve kids' health Data and Results Sharing our Results Integrity and Transparency Building Trust Diversity Equity and Representation Plain Language Study Results Trial Result Summaries Expanded AccessCompassionate Use Possible Treatment Options Find a Trial Areas of Focus Rare Disease Smaller populations but big impact Internal Medicine Extending lifespans worldwide InflammationImmunology Treatment at the molecular level Vaccines Preventing the spread of infections Oncology The science of optimism Anti Infectives Combatting an evolving risk Areas of Innovation Gene Therapy Breakthroughs become treatments Medicinal Sciences The next generation of science Precision Medicine Developing tailored medicines Maternal Immunization Protecting newborns at the start mRNA Technology Unleashing the next wave of scientific innovations DiseasesConditions Coronavirus Resources Product Pipeline Research Sites Products How Drugs Are Made Branded vs. Generic Learn the difference BiologicsBiosimilars Cures found in nature Commitment to Quality Maintaining the highest standards Global Supply Strategic manufacturing locations Manufacturing Sites Where medicine is made in the U.S. Medicine Safety Health Literacy Learning to be well Treatment Choices Learning about treatment decisions Partnering with Patients Helping others by reporting side effects Tips for Patients Preventing medication errors Reporting Adverse Events Counterfeiting Preventing medication errors Safety Data Sheets Product List Product Contacts PfizerPro for Professionals Patient Assistance Programs Distributors Pfizer Distributors Greenstone Distributors Stories Articles Announcements Behind the Science Features Online Counterfeit Medicines Combating the Rise When AI Meets Biology A Special Partnership What is mRNA? mRNA Defined and Applied COVID-19 Vaccine Rollout New Digital Technologies COVID-19 Vaccine Distributing Hope to the World Clinical Trials Where Science Meets Patients Medicinal Sciences The Art of Creating New Medicines Podcasts eBooks Newsroom Press Releases Media Asset Library UpdateStatements Partnering News Media Contacts About People Executives Our senior-most leadership Board Members The people steering our company Scientists Our experts making discoveries Patient Stories Our patients Colleague Stories Our colleagues Responsibility EthicsCompliance Each of us is responsible Responsible Business Breakthroughs that change patients’ lives Patient AdvocacyEngagement Putting Patients First Global Impact Meeting urgent needs worldwide Diversity, Equity, and Inclusion Everyone has something to offer Environmental Sustainability Our responsibility to the environment Human Rights Futhering dignity and worth HealthSafety Intellectual Property The benefits of fair competition EHS Governance Misinformation ProgramsPolicies Grants Support for independent research Political Partnership Supporting like-minded organizations Working with Healthcare Professionals Collaboration to improve lives Prescription ValuePricing How to lower patient costs Privacy Principles Commitment to personal data privacy Ready for Cures Improving Access to Medicines Transparency in Grants Committed to Disclosure Investors Investors Overview Information for stockholders Why Invest Why to join us on our mission EventsPresentations Calendar of upcoming events Financial Reports Quarterly reports and more Investor News Announcements about our performance Stock Information Charts and data Shareholder Services Information on stock transactions Corporate Governance Corporate Governance Overview Gaining insight into our performance Board CommitteesCharters Defining the corporate structure The Pfizer Board Policies Ensuring ethical leadership Corporate Governance FAQs Learn more about our approach Contact Our Directors Email any of our Directors Purpose History Careers Search Jobs Career GrowthDevelopment Connect With Us Partners Research and Business Development Partnerships Venture Investments Business to Business Pfizer CentreOne Pfizer Ignite Submit Your OpportunitiesCurrent Location and Language United States - English Argentina - Español Australia - English Austria - Deutsch Belarus - Belarusian - English Belgium - English - Nederlands - Français Brazil - Português Bulgaria - Български Canada - English - Français China - 中文 - English Chile - Español Colombia - Español Croatia - Croatian Czech Republic - Čeština Denmark - Dansk Ecuador - Español Estonia - Eesti - English Finland - Suomalainen France - Français Germany - Deutsch Greece - ελληνικά Hong Kong - 繁體中文 - English Hungary - Magyar India - English Indonesia - Indonesian Ireland - English Israel - עברית Italy - Italiano Japan - 日本の Korea - 한국의 Latvia - Latvian - English Lithuania - Lithuanian - English Malaysia - English Mexico - Español Netherlands - Nederlands New Zealand - English Norway - Norsk Pakistan - English Peru - Español Philippines - English Poland - Polski Portugal - Português Russia - Русский Romania - Română Serbia - Serbian Saudi Arabia - English - العربية Singapore - English Slovenia - Slovenian Slovakia - Slovenský South Africa - English Spain - Español Sweden - Svenska Switzerland - Deutsch - Français Taiwan - Taiwan Thailand - ภาษาไทย Tunisia - Français Turkey - Türk United Kingdom - English United States - English Ukraine - Ukrainian Vietnam - Tiếng Việt - English Venezuela - Español Investor Relations 02.29.2024 Pfizer Oncology Innovation Day Event AnnouncementPresentation Infographic Transcript Webcast Overview Investor Relations Overview Why Invest Our Story Prospective Investors Sustainability Bond ESG Report Fact Sheet Investor Email Alerts EventsPresentations Financials Quarterly Results Annual Reports SEC Filings News Stock Info Stock Quote Stock Chart Historical Stock Quote Investment Calculator DividendSplit History Stock FAQs Corporate Governance Corporate Governance Overview Board of Directors Board CommitteesCharters Corporate Governance Documents Board Policies Corporate Governance FAQs Contact Our Directors More Resources Shareholder Services Shareholder Services Overview Pfizer Investor Insights Stock FAQs Cost Basis Calculator Science Clinical Trials Guide to Clinical Trials Your participation makes a difference Clinical Trials in Children Designed to improve kids' health Data and Results Sharing our Results Integrity and Transparency Building Trust Diversity Equity and Representation Plain Language Study Results Trial Result Summaries Expanded AccessCompassionate Use Possible Treatment Options Find a Trial Areas of Focus Rare Disease Smaller populations but big impact Internal Medicine Extending lifespans worldwide InflammationImmunology Treatment at the molecular level Vaccines Preventing the spread of infections Oncology The science of optimism Anti Infectives Combatting an evolving risk Areas of Innovation Gene Therapy Breakthroughs become treatments Medicinal Sciences The next generation of science Precision Medicine Developing tailored medicines Maternal Immunization Protecting newborns at the...
Domain Name: SEAGEN.COM Registry Domain ID: 944835_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.corporatedomains.com Registrar URL: http://cscdbs.com Updated Date: 2023-11-30T06:05:41Z Creation Date: 1997-12-05T05:00:00Z Registry Expiry Date: 2024-12-04T05:00:00Z Registrar: CSC Corporate Domains, Inc. Registrar IANA ID: 299 Registrar Abuse Contact Email: domainabuse@cscglobal.com Registrar Abuse Contact Phone: 8887802723 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS1-01.AZURE-DNS.COM Name Server: NS2-01.AZURE-DNS.NET Name Server: NS3-01.AZURE-DNS.ORG Name Server: NS4-01.AZURE-DNS.INFO DNSSEC: unsigned >>> Last update of whois database: 2024-05-17T13:04:03Z <<<